CHRISTOPHER BELL: Open Payments
NPI 1982193660 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 34 payments from 16 companies in 2025. Trend: 2023 $261 · 2024 $2,945 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $283 |
| AtriCure, Inc. | 5 | $211 |
| Merck Sharp & Dohme LLC | 7 | $133 |
| Biosense Webster, Inc. | 1 | $73 |
| CVRx, Inc. | 2 | $44 |
| Impulse Dynamics (USA) Inc. | 1 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $24 |
| ABIOMED | 1 | $24 |
Products named: ATRICLIP LAA EXCLUSION SYSTEM, VERQUVO, S-ICD System Magnet, General - Therapies, CARTO 3, CDS - MCT/CEM Monitoring, Barostim Neo System, Optimizer.
Industry payments across OH — which companies pay providers there.
